Sale!
Sale!
Abetis 40mg
Original price was: 151.0 ৳ .149.5 ৳ Current price is: 149.5 ৳ .
ACI Pharmaceuticals.
Name Abetis
Generic Olmesartan medoxomi INN
Type Tablet
In stock (can be backordered)
Related Products
-
Novelta chewable
Original price was: 100.0 ৳ .99.0 ৳ Current price is: 99.0 ৳ .Add to cartOrion Pharma Ltd.
Name Novelta chewableGeneric Magaldrate BP 480mg + simethicone USP 20mg/tablet(chewable)Type Tablet -
Ripril 1.25mg
Original price was: 76.0 ৳ .75.2 ৳ Current price is: 75.2 ৳ . -
Purifen 300mg
Original price was: 16.0 ৳ .15.8 ৳ Current price is: 15.8 ৳ . -
Idatix SR 1.5mg
Original price was: 250.0 ৳ .247.5 ৳ Current price is: 247.5 ৳ . -
Dorel plus 75mg
Original price was: 111.0 ৳ .109.9 ৳ Current price is: 109.9 ৳ . -
Viglimet 50/850mg
Original price was: 115.0 ৳ .113.9 ৳ Current price is: 113.9 ৳ . -
Efigrel 10mg
Original price was: 200.0 ৳ .198.0 ৳ Current price is: 198.0 ৳ . -
Valsartil 80mg
Original price was: 90.0 ৳ .89.1 ৳ Current price is: 89.1 ৳ . -
Hedex 500mg
Original price was: 16.0 ৳ .15.8 ৳ Current price is: 15.8 ৳ . -
Eto 90mg
Original price was: 100.0 ৳ .99.0 ৳ Current price is: 99.0 ৳ . -
Carva 75mg
Original price was: 6.0 ৳ .5.9 ৳ Current price is: 5.9 ৳ . -
Febustat 40mg 10pis
Original price was: 220.0 ৳ .217.8 ৳ Current price is: 217.8 ৳ . -
Zomitan 2.5mg
Original price was: 250.0 ৳ .247.5 ৳ Current price is: 247.5 ৳ . -
Clofenac 25mg
Original price was: 10.0 ৳ .9.9 ৳ Current price is: 9.9 ৳ . -
Melcam 15mg
Original price was: 41.0 ৳ .40.6 ৳ Current price is: 40.6 ৳ . -
Abecab 20/5mg
Original price was: 81.0 ৳ .80.2 ৳ Current price is: 80.2 ৳ . -
Deprex 10mg
Original price was: 45.0 ৳ .44.6 ৳ Current price is: 44.6 ৳ . -
Neso 375/20mg
Original price was: 32.0 ৳ .31.7 ৳ Current price is: 31.7 ৳ . -
Xibra 120mg
Original price was: 140.0 ৳ .138.6 ৳ Current price is: 138.6 ৳ . -
Peuritar 1 17mg
Original price was: 52.0 ৳ .51.5 ৳ Current price is: 51.5 ৳ .Add to cartSquare Pharmaceuticals Ltd.Name Peuritar 1Generic Sodium dichloroisocyanurate INNType Tablet
Reviews
There are no reviews yet.